New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 16, 2014
09:25 EDTAVTH, AVTH, SSET, SSET, AWK, AWK, NBS, NBS, SNWV, SNWV, ATNM, ATNM, VTEQ, VTEQ, AKER, AKER, CGIX, CGIX, DIRI, DIRIRedChip Companies to hold a virtual conference
Global Online CEO Conference to be held on July 16-17 with webcasted presentations to begin on July 16 at 9:30 am. Webcast Link
News For AVTH;CGIX;AKER;VTEQ;ATNM;SNWV;NBS;AWK;SSET;DIRI From The Last 14 Days
Check below for free stories on AVTH;CGIX;AKER;VTEQ;ATNM;SNWV;NBS;AWK;SSET;DIRI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 30, 2014
07:17 EDTATNMActinium adds Baylor Sammons Cancer Center as clinical trial site
Subscribe for More Information
July 28, 2014
05:33 EDTAKERAkers Biosciences signs feasibility study deal with Konica Minolta
Akers Biosciences (AKER) has signed a feasibility study deal with Konica Minolta, Inc. (KNCAY) to develop a rapid test for the early detection of cardiac muscle tissue damage a condition commonly observed in patients suffering myocardial infarction. Heart attacks are the leading cause of death in U.S., with approximately 1.1M Americans suffering heart attacks each year. Konica Minolta, has asked Akers to study a diagnostic test based on Akers' proprietary Particle Immuno Filtration Assay, or PIFA, technology which, if successful, will facilitate the rapid detection of biomarkers present in a blood sample which can be used to identify cardiac muscle tissue damage. Such tissue damage can occur even at the early stages of a heart attack so early diagnosis could have a significant beneficial impact on patient treatment. The PIFA technology, when combined with Akers' proprietary Rapid Blood Cell Separation Technology, seraSTAT, permits the testing of whole blood from a finger prick sample allowing a test to be carried out in minutes at the point of care. Currently available tests for cardiac muscle tissue damage require a blood draw and the use of an interpretation device; and typically take 20-30 minutes to complete in a laboratory. Konica Minolta, at its own cost, has asked Akers to study a test which can be performed in under 10 minutes, using only a small blood sample obtained from a finger stick; and which can be read visually at the point of care.
July 22, 2014
10:00 EDTATNMOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Abengoa Yield (ABY) initiated with an Equal Weight at Morgan Stanley... Actinium Pharmaceuticals (ATNM) initiated with a Buy at Canaccord... Axys Technologies (AXYS) initiated with a Buy at Dougherty... Chambers Street Properties (CSG) initiated with a Neutral at SunTrust... Enphase Energy (ENPH) initiated with a Buy at Dougherty... Minerals Technologies (MTX) initiated with an Outperform at Wedbush... NextEra Energy Partners (NEP) initiated with a Buy at BofA/Merrill... PTC Therapeutics (PTCT) initiated with a Buy at BofA/Merrill... QIWI (QIWI) initiated with a Positive at Susquehanna... Quality Systems (QSII) initiated with a Buy at Topeka... Sarepta (SRPT) initiated with a Neutral at BofA/Merrill... Trinseo S.A. (TSE) initiated with a Buy at BofA/Merrill... Washington Prime Group (WPG) initiated with a Neutral at SunTrust... Zhaopin (ZPIN) initiated with a Buy at UBS.
06:33 EDTATNMActinium Pharmaceuticals initiated with a Buy at Canaccord
Subscribe for More Information
July 21, 2014
07:47 EDTCGIXCancer Genetics to acquire Gentris
Subscribe for More Information
July 17, 2014
05:47 EDTAKERAkers announces U.S. patent granted for Breath Ketone detection device
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use